Examkin

Soru

Zorluk: Çok zorCardiovascular System

Brought to the emergency department via ambulance, a 68-year-old individual presents with acute-onset, severe dyspnea and loud wheezing that rapidly worsened over the past 2 hours. The patient has a history of hypertension, a 50-pack-year smoking history, and a remote anterior myocardial infarction. On arrival, the patient is diaphoretic, unable to speak in full sentences, and actively using accessory respiratory muscles. Vital signs show a blood pressure of 192/110 mmHg, a heart rate of 124/min, a respiratory rate of 32/min, and an oxygen saturation of 82% on room air. Physical examination is notable for a prolonged expiratory phase and diffuse bilateral polyphonic wheezes; no crackles are auscultated. Jugular venous pressure is evaluated at 15 cm H2O. Cardiac auscultation reveals a regular tachycardia and a prominent S3 gallop. A portable chest radiograph demonstrates hyperinflated lung fields, a widened vascular pedicle, and peribronchial cuffing, without lobar consolidation. Bedside lung ultrasound reveals diffuse bilateral B-lines. Which of the following is the most appropriate initial pharmacological therapy for this patient?

  1. Intravenous nitroglycerinCevap
  2. B
    Inhaled albuterol and ipratropium
  3. C
    Intravenous methylprednisolone
  4. D
    Intravenous labetalol
  5. E
    Intravenous ceftriaxone and azithromycin

Cevap

Intravenous nitroglycerin
This patient is experiencing Sympathetic Crashing Acute Pulmonary Edema (SCAPE), a severe form of acute decompensated heart failure (ADHF) characterized by sudden, extreme hypertension and flash pulmonary edema. Although the patient's smoking history and prominent wheezing strongly suggest a COPD exacerbation, the elevated jugular venous pressure, S3 gallop, widened vascular pedicle, peribronchial cuffing, and diffuse bilateral B-lines on lung ultrasound confirm a primary cardiogenic etiology. The wheezing is due to peribronchial interstitial edema causing airway compression, classically termed 'cardiac asthma'. In hypertensive ADHF, the immediate priority is rapid afterload and preload reduction. Intravenous nitroglycerin is the pharmacological agent of choice as it acts rapidly to decrease systemic vascular resistance and venous return, immediately relieving pulmonary congestion and decreasing myocardial oxygen demand.

Adım Adım Çözüm

1
Evaluate the clinical presentation and physical exam findings.
The patient has severe respiratory distress, marked hypertension, wheezing, elevated jugular venous pressure, and an S3 gallop.
To differentiate between pulmonary (COPD exacerbation) and cardiac (acute decompensated heart failure) causes of acute dyspnea.
2
Interpret the objective imaging findings from the radiograph and ultrasound.
Findings include a widened vascular pedicle, peribronchial cuffing, and diffuse bilateral B-lines.
To confirm the presence of interstitial pulmonary edema, which definitively points toward a cardiogenic etiology over isolated primary airway disease.
3
Synthesize the findings to establish a diagnosis.
The presentation is consistent with Sympathetic Crashing Acute Pulmonary Edema (SCAPE) presenting with 'cardiac asthma' (wheezing due to peribronchial edema compressing airways).
Recognizing that severe wheezing can be driven by heart failure, especially when accompanied by extreme hypertension and an S3 gallop.
4
Determine the optimal initial pharmacological intervention.
Intravenous nitroglycerin is the treatment of choice.
It provides rapid venodilation and arterial afterload reduction, redistributing fluid away from the lungs and decreasing the workload on the failing left ventricle.

Anahtar Kavram

Differentiating cardiac asthma (acute decompensated heart failure) from a COPD exacerbation and recognizing the essential role of rapid afterload reduction in hypertensive acute pulmonary edema.
Bu soruyu puanla

Konular

Cardiovascular System

Bu konudan daha fazla soru